Skip to main content
Premium Trial:

Request an Annual Quote

Hologic Completes $950M Senior Notes Offering

NEW YORK ─ Hologic said after the close of the market on Monday that it has completed a previously announced private placement of $950 million of its senior notes.

In a filing with the US Securities and Exchange Commission, the firm said the notes, carrying 3.25 percent interest, are due on Feb. 15, 2029.

The notes are general senior unsecured obligations of Hologic guaranteed by certain of its domestic subsidiaries, and they were issued in accordance with an agreement dated Sept. 28 among Hologic, the subsidiaries of the firm, and Wells Fargo Bank, National Association as the trustee.

Hologic had previously disclosed that it intends to use the net proceeds of the notes, plus available cash, to redeem in full all of its outstanding 4.375 percent senior notes due in 2025, in an aggregate principal amount of $950 million on or about Oct. 15.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more